161 related articles for article (PubMed ID: 24492945)
1. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.
Hoffman KE; Pugh SL; James JL; Scarantino C; Movsas B; Valicenti RK; Fortin A; Pollock J; Kim H; Brachman DG; Berk LB; Bruner DW; Kachnic LA
Qual Life Res; 2014 Aug; 23(6):1841-58. PubMed ID: 24492945
[TBL] [Abstract][Full Text] [Related]
2. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
[TBL] [Abstract][Full Text] [Related]
4. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study.
Saarilahti K; Kajanti M; Joensuu T; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):479-85. PubMed ID: 12243825
[TBL] [Abstract][Full Text] [Related]
5. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study.
Makkonen TA; Minn H; Jekunen A; Vilja P; Tuominen J; Joensuu H
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):525-34. PubMed ID: 10701730
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy.
Rovirosa A; Ferre J; Biete A
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):747-54. PubMed ID: 9652834
[TBL] [Abstract][Full Text] [Related]
8. The optimal use of granulocyte macrophage colony stimulating factor in radiation induced mucositis in head and neck squamous cell carcinoma.
Patni N; Patni S; Bapna A
J Cancer Res Ther; 2005; 1(3):136-41. PubMed ID: 17998644
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer.
McAleese JJ; Bishop KM; A'Hern R; Henk JM
Br J Radiol; 2006 Jul; 79(943):608-13. PubMed ID: 16823067
[TBL] [Abstract][Full Text] [Related]
10. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.
Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY
J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716
[TBL] [Abstract][Full Text] [Related]
11. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis.
Sprinzl GM; Galvan O; de Vries A; Ulmer H; Gunkel AR; Lukas P; Thumfart WF
Eur J Cancer; 2001 Nov; 37(16):2003-9. PubMed ID: 11597377
[TBL] [Abstract][Full Text] [Related]
12. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
13. A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis.
Hawley P; Hovan A; McGahan CE; Saunders D
Support Care Cancer; 2014 Mar; 22(3):751-61. PubMed ID: 24221577
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report.
Nicolatou O; Sotiropoulou-Lontou A; Skarlatos J; Kyprianou K; Kolitsi G; Dardoufas K
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):551-6. PubMed ID: 9806514
[TBL] [Abstract][Full Text] [Related]
15. Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial.
Uyl-de Groot CA; Vellenga E; de Vries EG; Löwenberg B; Stoter GJ; Rutten FF
Pharmacoeconomics; 1997 Sep; 12(3):351-60. PubMed ID: 10170460
[TBL] [Abstract][Full Text] [Related]
16. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI).
Trotti A; Johnson DJ; Gwede C; Casey L; Sauder B; Cantor A; Pearlman J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):257-61. PubMed ID: 9788402
[TBL] [Abstract][Full Text] [Related]
17. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.
Nicolatou-Galitis O; Dardoufas K; Markoulatos P; Sotiropoulou-Lontou A; Kyprianou K; Kolitsi G; Pissakas G; Skarleas C; Kouloulias V; Papanicolaou V; Legakis NJ; Velegraki A
J Oral Pathol Med; 2001 Sep; 30(8):471-80. PubMed ID: 11545238
[TBL] [Abstract][Full Text] [Related]
18. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
Anderson CM; Lee CM; Saunders DP; Curtis A; Dunlap N; Nangia C; Lee AS; Gordon SM; Kovoor P; Arevalo-Araujo R; Bar-Ad V; Peddada A; Colvett K; Miller D; Jain AK; Wheeler J; Blakaj D; Bonomi M; Agarwala SS; Garg M; Worden F; Holmlund J; Brill JM; Downs M; Sonis ST; Katz S; Buatti JM
J Clin Oncol; 2019 Dec; 37(34):3256-3265. PubMed ID: 31618127
[TBL] [Abstract][Full Text] [Related]
19. Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study Group.
Angel JB; High K; Rhame F; Brand D; Whitmore JB; Agosti JM; Gilbert MJ; Deresinski S
AIDS; 2000 Mar; 14(4):387-95. PubMed ID: 10770541
[TBL] [Abstract][Full Text] [Related]
20. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients.
Ibrahim EM; al-Mulhim FA
Med Oncol; 1997 Mar; 14(1):47-51. PubMed ID: 9232612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
